HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platycodi Radix attenuates dimethylnitrosamine-induced liver fibrosis in rats by inducing Nrf2-mediated antioxidant enzymes.

Abstract
The purpose of this study was to investigate the anti-fibrotic effects of the aqueous extract of the Platycodi Radix root (Changkil: CK) on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. DMN treatment for 4 weeks led to marked liver fibrosis as assessed by serum biochemistry, histopathological examination, and hepatic lipid peroxidation and collagen content. CK significantly inhibited DMN-induced increases in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, fibrosis score, and hepatic malondialdehyde and collagen content. CK also inhibited DMN-induced reductions in rat body and liver weights. Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited DMN-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-α (TNF-α) mRNA, and collagen type I and α-smooth muscle actin protein. DMN-induced cyclooxygenase-2 (COX-2) expression and nuclear factor-kappa B (NF-κB) activation was reduced by CK treatment. Furthermore, CK induced activation of nuclear erythroid 2-related factor 2 (Nrf2)-mediated antioxidant enzymes such as γ-glutamylcysteine synthetase (γ-GCS), heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutathione-S-transferase (GST) in HepG2 cells. These results demonstrated that CK attenuates DMN-induced liver fibrosis through the activation of Nrf2-mediated antioxidant enzymes.
AuthorsJae Ho Choi, Sun Woo Jin, Hyung Gyun Kim, Tilak Khanal, Yong Pil Hwang, Kyung Jin Lee, Chul Yung Choi, Young Chul Chung, Young Chun Lee, Hye Gwang Jeong
JournalFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association (Food Chem Toxicol) Vol. 56 Pg. 231-9 (Jun 2013) ISSN: 1873-6351 [Electronic] England
PMID23485615 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Actins
  • Antioxidants
  • Changkil
  • Collagen Type I
  • NF-E2-Related Factor 2
  • NF-kappa B
  • Nfe2l2 protein, rat
  • Plant Extracts
  • RNA, Messenger
  • TIMP1 protein, rat
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Necrosis Factor-alpha
  • smooth muscle actin, rat
  • Malondialdehyde
  • Heme Oxygenase (Decyclizing)
  • Hmox1 protein, rat
  • Cyclooxygenase 2
  • Ptgs2 protein, rat
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, rat
  • Glutathione Transferase
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Matrix Metalloproteinase 13
  • Mmp13 protein, rat
  • Glutamate-Cysteine Ligase
  • Dimethylnitrosamine
Topics
  • Actins (metabolism)
  • Alanine Transaminase (blood)
  • Animals
  • Antioxidants (pharmacology)
  • Aspartate Aminotransferases (blood)
  • Collagen Type I (metabolism)
  • Cyclooxygenase 2 (metabolism)
  • Dimethylnitrosamine (adverse effects)
  • Glutamate-Cysteine Ligase (metabolism)
  • Glutathione Transferase (metabolism)
  • Heme Oxygenase (Decyclizing) (metabolism)
  • Hep G2 Cells
  • Humans
  • Lipid Peroxidation (drug effects)
  • Liver (drug effects, enzymology, pathology)
  • Liver Cirrhosis (chemically induced, drug therapy, pathology)
  • Male
  • Malondialdehyde (blood)
  • Matrix Metalloproteinase 13 (metabolism)
  • NAD(P)H Dehydrogenase (Quinone) (metabolism)
  • NF-E2-Related Factor 2 (metabolism)
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Plant Extracts (pharmacology)
  • Plant Roots (chemistry)
  • Platycodon
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Inhibitor of Metalloproteinase-1 (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: